| HEPA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the HEPA market cap history going back to 6/3/2019:
Also see: HEPA Shares Outstanding History and HEPA YTD Return |
HEPA Market Cap History — Hepion Pharmaceuticals Capitalization Over Time
As of 5/14/2026 Hepion Pharmaceuticals has a market cap of 2.77 million. Investors often follow the HEPA market cap history to compare the size of the company over time.
This page shows HEPA market capitalization trends over time, with 29 market cap datapoints presented, dating back to 6/3/2019.
| HEPA Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
HEPA Historical Market Cap: -2.53% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HEPA Stock Price Chart |
| About Hepion Pharmaceuticals Inc |
| Hepion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development of drug therapy for treatment of chronic liver diseases. Co. is developing a treatment for non-alcoholic steatohepatitis (NASH), hepatocellular carcinoma (HCC), and other chronic liver diseases. Its cyclophilin inhibitor, rencofilstat, is being developed to offer benefits to address multiple complex pathologies related to the progression of liver disease. It is developing rencofilstat as its lead molecule. We show 29 historical shares outstanding datapoints in our HEPA shares outstanding history coverage, used to compute HEPA market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing HEPA market cap history over the course of time is important for investors interested in comparing HEPA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of HEPA versus a peer is one thing; comparing HEPA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like HEPA can fluctuate over the course of history. With this page we aim to empower investors researching HEPA by allowing them to research the HEPA market cap history. |
| HEPA Current Stock Quote |
Quotes delayed 20 minutes  Free HEPA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| HEPA Share Performance |
| Market Cap Peers |
| Hepion Pharmaceuticals (HEPA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
HGEN Market Cap History HILS Market Cap History HIMS Market Cap History HJLI Market Cap History HLTH Market Cap History HLVX Market Cap History HMSY Market Cap History HNGR Market Cap History HOLX Market Cap History HOOK Market Cap History More Healthcare companies » |
HEPA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
